We have developed a cost-effective DNA methylation sequencing assay to improve monitoring of clonal hematopoiesis. By inferring cell-type proportions, this method enhances interpretation of clonal trajectories compared to interpretation based on variant allele fraction only.

Subjects:
Hematopoiesis and Stem Cells
This content is only available as a PDF.
Copyright © 2024 American Society of Hematology
2024

Article PDF first page preview

Article PDF first page preview
You do not currently have access to this content.
Sign in via your Institution